Pay in 4 interest-free payments of $7.12 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Cells were then selected and maintained in culture media containing 1 g/mL of puromycin
H.MorisseS.TrostP.LemaireS
Important caveat: the combination is not clinically validated
The development of exosome-based delivery platforms is particularly attractive, as exosomes exhibit excellent biocompatibility, low immunogenicity, and the ability to cross biological barriers, making them ideal nanocarriers for gene therapy in osteosarcoma (6567)
US$ 25.08
US$ 29.28
US$ 23.20
US$ 26.71
